BBA
IGMS
Baker Bros. Advisors’s IGM Biosciences IGMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.59M | Buy |
4,096,210
+953
| +0% | +$1.07K | 0.04% | 69 |
|
|
2025
Q1 | $4.71M | Buy |
4,095,257
+953
| +0% | +$1.1K | 0.05% | 59 |
|
|
2024
Q4 | $25M | Buy |
4,094,304
+1,994
| +0% | +$12.2K | 0.27% | 41 |
|
|
2024
Q3 | $67.7M | Buy |
4,092,310
+1,994
| +0% | +$33K | 0.7% | 22 |
|
|
2024
Q2 | $28.1M | Buy |
4,090,316
+1,994
| +0% | +$13.7K | 0.36% | 35 |
|
|
2024
Q1 | $39.5M | Buy |
4,088,322
+397,311
| +11% | +$3.83M | 0.49% | 31 |
|
|
2023
Q4 | $30.7M | Buy |
3,691,011
+533,247
| +17% | +$4.43M | 0.35% | 33 |
|
|
2023
Q3 | $26.4M | Buy |
3,157,764
+554
| +0% | +$4.63K | 0.15% | 32 |
|
|
2023
Q2 | $29.1M | Buy |
3,157,210
+554
| +0% | +$5.11K | 0.17% | 33 |
|
|
2023
Q1 | $43.4M | Buy |
3,156,656
+554
| +0% | +$7.61K | 0.24% | 24 |
|
|
2022
Q4 | $53.7M | Hold |
3,156,102
| – | – | 0.32% | 24 |
|
|
2022
Q3 | $71.8M | Hold |
3,156,102
| – | – | 0.47% | 20 |
|
|
2022
Q2 | $56.9M | Hold |
3,156,102
| – | – | 0.32% | 20 |
|
|
2022
Q1 | $84.4M | Hold |
3,156,102
| – | – | 0.48% | 17 |
|
|
2021
Q4 | $92.6M | Hold |
3,156,102
| – | – | 0.45% | 20 |
|
|
2021
Q3 | $208M | Hold |
3,156,102
| – | – | 0.91% | 13 |
|
|
2021
Q2 | $263M | Hold |
3,156,102
| – | – | 1.15% | 11 |
|
|
2021
Q1 | $242M | Buy |
3,156,102
+11,210
| +0.4% | +$860K | 1.05% | 13 |
|
|
2020
Q4 | $278M | Buy |
3,144,892
+446
| +0% | +$39.4K | 1.05% | 14 |
|
|
2020
Q3 | $232M | Buy |
3,144,446
+223
| +0% | +$16.5K | 0.93% | 14 |
|
|
2020
Q2 | $230M | Buy |
3,144,223
+223
| +0% | +$16.3K | 1.01% | 13 |
|
|
2020
Q1 | $177M | Hold |
3,144,000
| – | – | 1.09% | 9 |
|
|
2019
Q4 | $120M | Hold |
3,144,000
| – | – | 0.64% | 18 |
|
|
2019
Q3 | $55.8M | Buy |
+3,144,000
| New | +$55.8M | 0.38% | 21 |
|